BackEditas Medicine Overview

Editas Medicine Current Cash

Track Editas Medicine's current cash ($180M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$181.81M
↑ 31.23% YoYΔ $43.27M vs prior year quarter

Peer average / median

Loading

Editas Medicine Current Cash History

Loading

Editas Medicine vs. peers: Current Cash Comparison

Loading

Editas Medicine Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Editas Medicine (EDIT) FAQ

Editas Medicine (EDIT) currently reports a current cash of $180M as of June 2026. That compares with $140M in the prior-year period — up 31.2% year over year. Use the charts on this page to explore Editas Medicine's current cash history and peer comparisons.

Editas Medicine's current cash increased from $140M to $180M — a 31.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Editas Medicine reported $180M in current cash as of June 2026. That compares with $140M in the prior-year period — up 31.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Editas Medicine, and consider following EDIT for alerts when major investors trade the stock.

Editas Medicine is classified in the Healthcare sector. On current cash, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EDIT with unrelated industries.